Evidence map›Paper›PMID 38991034›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2024

Factors Associated With Unfavorable Treatment Outcomes Among Persons With Pulmonary Tuberculosis: A Multicentric Prospective Cohort Study From India.

Senbagavalli Prakash Babu, Komala Ezhumalai, Kalaivani Raghupathy, Meagan Karoly, Palanivel Chinnakali, Nikhil Gupte, Mandar Paradkar, Arutselvi Devarajan, Mythili Dhanasekaran, Kannan Thiruvengadam and 19 more

Abstract readMulticenter Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Senbagavalli Prakash BabuDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Komala EzhumalaiDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Kalaivani RaghupathyDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Meagan KarolySection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Palanivel ChinnakaliDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Nikhil GupteByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Mandar ParadkarByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Arutselvi DevarajanProf. M. Viswanathan Diabetes Research Centre, Chennai, Tamil Nadu, India.
Mythili DhanasekaranProf. M. Viswanathan Diabetes Research Centre, Chennai, Tamil Nadu, India.
Kannan ThiruvengadamIndian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Madolyn Rose DauphinaisSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Akshay N GupteSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Shrivijay Balayogendra ShivakumarCenter for Infectious Diseases, Johns Hopkins India, Pune, Maharashtra, India.
Balamugesh ThangakunamDepartment of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
Devasahayam Jesudas ChristopherDepartment of Pulmonary Medicine, Christian Medical College, Vellore, Tamil Nadu, India.
Vijay ViswanathanProf. M. Viswanathan Diabetes Research Centre, Chennai, Tamil Nadu, India.
Vidya MaveByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Sanjay GaikwadByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Aarti KinikarByramjee Jeejeebhoy Government Medical College and Sassoon General Hospitals, Johns Hopkins University Clinical Research Site, Pune, Maharashtra, India.
Hardy KornfeldDepartment of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
C Robert HorsburghSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Padmapriyadarsini ChandrasekaranIndian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu, India.
Natasha S HochbergSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Padmini SalgameDepartment of Medicine, Center for Emerging Pathogens, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
Amita GuptaDivision of Infectious Diseases, Center for Clinical Global Health Education, Johns Hopkins University, School of Medicine, Baltimore, Maryland, USA.
Gautam RoyDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.
Jerrold EllnerDepartment of Medicine, Center for Emerging Pathogens, New Jersey Medical School, Rutgers Biomedical and Health Sciences, Newark, New Jersey, USA.
Pranay SinhaSection of Infectious Diseases, Department of Medicine, Boston Medical Center, Boston, Massachusetts, USA.
Sonali SarkarDepartment of Preventive and Social Medicine, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India.

Funding

Nutritional Interventions to End Tuberculosis among Persons with HIV (NUTRIENT)K01AI167733 · NIAID · BOSTON MEDICAL CENTER · PI Pranay Sinha · 2023 to 2026
$512k
GlobalNational Institute of Allergy and Infectious DiseasesNIAID NIH HHS K01 AI167733NIHOffice of AIDS Research
6 · The paper itself

Abstract

In this prospective cohort of 2006 individuals with drug-susceptible tuberculosis in India, 18% had unfavorable treatment outcomes (4.7% treatment failure, 2.5% recurrent infection, 4.1% death, 6.8% loss to follow-up) over a median 12-month follow-up period. Age, male sex, low education, nutritional status, and alcohol use were predictors of unfavorable outcomes.

Indexed as

Antitubercular AgentsTuberculosis, PulmonaryAdolescentAdultAgedCohort StudiesFemaleHumansIndiaMaleMiddle AgedProspective StudiesRisk FactorsTreatment FailureTreatment OutcomeYoung AdultAntitubercular Agentsepidemiologyprospective cohortrisk factorstreatment outcometuberculosis

Identifiers

PMID38991034
PMCPMC11478802

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.